Overexpression of HIF-1α has been previously reported to correlate with angiogenesis [5], an aggressive phenotype [3,17] and poor outcome after conventional adjuvant therapy [18,19] in breast cancer. This evidence concerns the gene HIF1A and breast carcinoma.